Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tocladesine in Relapsed or Refractory Multiple Myeloma
NCT00004902Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Jan 1998
- Primary completion
- Nov 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cladribine in multiple myeloma (MM), sponsored by Northwestern University. Started Jan 1998; status: completed.
02
Drugs
cladribine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004902.